Skip to main content

Acorda Therapeutics, Inc.

ACORDelisted Apr 25, 2024
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001008848

Acorda Therapeutics, Inc. was delisted on Apr 25, 2024; its insiders filed their last Form 4 on Jun 23, 2023; 17 institutions reported holding it in 13F filings for Q1 2024, worth $2.13M in total; no superinvestor held it.

Superinvestors holding ACOR, Q1 2024

See all superinvestors

No superinvestor reported holding ACOR in Q1 2024.